皇冠现金网
热门标签

哈希竞彩游戏:Sanofi ends cancer drug trials

时间:1个月前   阅读:1   评论:4

皇冠体育官网www.hg108.vip)是一个开放皇冠正网即时比分、皇冠官方的平台。皇冠体育官网(www.hg108.vip)提供最新皇冠登录,皇冠体育官网包含新皇冠体育代理、会员APP,提供皇冠官网代理开户、皇冠官网会员开户业务。

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

PARIS: Sanofi is ending development of a key cancer medicine in a blow to the French drugmaker’s pipeline of experimental therapies.

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

The move leaves Sanofi even more dependent for growth on blockbuster Dupixent, an antibody treatment for ailments ranging from asthma to severe eczema.

The company’s slate of experimental medicines has faced other setbacks, including safety concerns regarding multiple sclerosis treatment tolebrutinib.

,

哈希竞彩游戏www.hx198.vip)采用波场区块链高度哈希值作为统计数据,游戏数据开源、公平、无任何作弊可能性,哈希竞彩游戏开放单双哈希、幸运哈希、哈希定位胆、哈希牛牛等游戏源码下载、出售。

,

Sanofi has included both amcenestrant and tolebrutinib as among six products in its pipeline that it prioritised as “potentially transformative” treatments.

Some investors are questioning the company’s growth trajectory after both of those medicines encountered problems.

UBS analysts last week downgraded Sanofi, saying there are few major catalysts coming soon to drive more excitement to the stock. — Bloomberg


转载说明:本文转载自Sunbet。

上一篇:哈希108竞彩平台(www.hx198.vip):台股拼站回月线 紧盯两动向

下一篇:Chi tiết sạc nhanh 210W của Xiaomi: 10 phút đầy pin, dùng 3 chip quản lý sạc và không hề quá nhiệt

网友评论

  • 2022-08-29 02:15:06

    “We expect to unlock more Asean plus global capital flows into India through this combined service,” she said.都可以当范本了

    • 2022-10-05 17:24:55

      @Telegram美国群(www.tel8.vip) Mức giảm hơn 11,5% đã đưa chứng khoán Việt Nam vào top các thị trường giảm mạnh nhất thế giới trong tháng 9. Đây là một kết quả đáng quên khi chỉ đúng một tháng trước VN-Index còn lọt top các chỉ số tăng mạnh nhất thế giới. Mức giảm hơn 11,5% trong tháng 9 cũng đã khiến vốn hóa HoSE đã bị “thổi bay” hơn 588.000 tỷ đồng (~25,13 tỷ USD), còn khoảng 4,5 triệu tỷ đồng.远超预期